Clozapine toxicity and coronavirus disease 2019: A case report
- PMID: 35030448
- PMCID: PMC8743391
- DOI: 10.1016/j.schres.2022.01.008
Clozapine toxicity and coronavirus disease 2019: A case report
Keywords: COVID-19; Clozapine; SARS-CoV-2; Schizophrenia; Toxicity.
Conflict of interest statement
HLP has received travel grants from the laboratories honoraria and travel grants from Janssen and Lundbeck; none of them has relationship with this research.
The other authors have no conflicts of interest to disclose.
Comment on
-
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.Psychother Psychosom. 2020;89(4):200-214. doi: 10.1159/000507638. Epub 2020 Apr 14. Psychother Psychosom. 2020. PMID: 32289791 Free PMC article. Review.
-
Consensus statement on the use of clozapine during the COVID-19 pandemic.J Psychiatry Neurosci. 2020 May 1;45(3):222-223. doi: 10.1503/jpn.200061. Epub 2020 Apr 3. J Psychiatry Neurosci. 2020. PMID: 32297722 Free PMC article. No abstract available.
References
-
- Couchman L., Morgan P.E., Spencer E.P., Flanagan R.J. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993–2007. Ther. Drug Monit. 2010;32(4):438–447. doi: 10.1097/FTD.0b013e3181dad1fb. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
